58 related articles for article (PubMed ID: 16118625)
1. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis.
Shim GJ; Wang L; Andersson S; Nagy N; Kis LL; Zhang Q; Mäkelä S; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2003 May; 100(11):6694-9. PubMed ID: 12740446
[TBL] [Abstract][Full Text] [Related]
2. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child.
Aktekin EH; Yazici N; Kozanoğlu İ; Erbay A
Lab Med; 2023 Nov; 54(6):e170-e176. PubMed ID: 37352366
[TBL] [Abstract][Full Text] [Related]
3. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.
Chan IT; Kutok JL; Williams IR; Cohen S; Kelly L; Shigematsu H; Johnson L; Akashi K; Tuveson DA; Jacks T; Gilliland DG
J Clin Invest; 2004 Feb; 113(4):528-38. PubMed ID: 14966562
[TBL] [Abstract][Full Text] [Related]
4. Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology.
Karantanos T; Jain T; Moliterno AR; Jones RJ; DeZern AE
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807519
[TBL] [Abstract][Full Text] [Related]
5. Leukemia secondary to myeloproliferative neoplasms.
Dunbar AJ; Rampal RK; Levine R
Blood; 2020 Jul; 136(1):61-70. PubMed ID: 32430500
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation.
Yeaton A; Cayanan G; Loghavi S; Dolgalev I; Leddin EM; Loo CE; Torabifard H; Nicolet D; Wang J; Corrigan K; Paraskevopoulou V; Starczynowski DT; Wang E; Abdel-Wahab O; Viny AD; Stone RM; Byrd JC; Guryanova OA; Kohli RM; Cisneros GA; Tsirigos A; Eisfeld AK; Aifantis I; Guillamot M
Cancer Discov; 2022 Oct; 12(10):2392-2413. PubMed ID: 35924979
[TBL] [Abstract][Full Text] [Related]
7. Isolation of lymph shows dysregulation of STAT3 and CREB pathways in the spleen and liver during leukemia development in a rat model.
Steinskog ESS; Finne K; Enger M; Helgeland L; Iversen PO; McCormack E; Wiig H; Tenstad O
Microcirculation; 2023 Apr; 30(2-3):e12800. PubMed ID: 36702790
[TBL] [Abstract][Full Text] [Related]
8. Myeloid sarcoma: Experience from a tertiary care center in southern India - A series of eight unusual cases.
Murugan R; Sharan KC; Srinivas BH; Basu D; Kar R; Jinkala SR; Stephen N; Kayal S
Indian J Pathol Microbiol; 2024 Jun; ():. PubMed ID: 38904435
[TBL] [Abstract][Full Text] [Related]
9. Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms.
Vieri M; Tharmapalan V; Kalmer M; Baumeister J; Nikolić M; Schnitker M; Kirschner M; Flosdorf N; de Toledo MAS; Zenke M; Koschmieder S; Brümmendorf TH; Beier F; Wagner W
Blood Cancer J; 2023 Nov; 13(1):164. PubMed ID: 37926720
[No Abstract] [Full Text] [Related]
10. Should we move to a genomic classification of neutrophilic myeloid neoplasms?
Carreño-Tarragona G; Álvarez-Larrán A; Hernández-Boluda JC; Ayala R; Cross NCP
Blood Adv; 2023 Nov; 7(21):6705-6706. PubMed ID: 37672387
[No Abstract] [Full Text] [Related]
11. Predicting the progression of patients with CCUS to myeloid neoplasia.
Groarke EM
Lancet Haematol; 2024 Jan; 11(1):e7-e8. PubMed ID: 38135374
[No Abstract] [Full Text] [Related]
12. G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors.
He K; Liu X; Hoffman RD; Shi RZ; Lv GY; Gao JL
FEBS Open Bio; 2022 Jul; 12(7):1268-1285. PubMed ID: 35612789
[TBL] [Abstract][Full Text] [Related]
13. The spleen microenvironment influences disease transformation in a mouse model of KIT
Pelusi N; Kosanke M; Riedt T; Rösseler C; Seré K; Li J; Gütgemann I; Zenke M; Janzen V; Schorle H
Sci Rep; 2017 Jan; 7():41427. PubMed ID: 28128288
[TBL] [Abstract][Full Text] [Related]
14. Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
Ciaffoni F; Cassella E; Varricchio L; Massa M; Barosi G; Migliaccio AR
Blood Cells Mol Dis; 2015 Mar; 54(3):234-41. PubMed ID: 25703685
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.
Martin-Padura I; Marighetti P; Gregato G; Agliano A; Malazzi O; Mancuso P; Pruneri G; Viale A; Bertolini F
Neoplasia; 2012 Nov; 14(11):1057-66. PubMed ID: 23226099
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of X-Chromosome Inactivation Patterns in Patients with Acute Myeloid Leukemia during Remission.
Mortazavi Y; Kaviani S; Mirzamohammadi F; Alimoghaddam K; Pourfathollah AA; Salehi O
ISRN Hematol; 2012; 2012():971493. PubMed ID: 23150832
[TBL] [Abstract][Full Text] [Related]
17. Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.
Prakash S; Hoffman R; Barouk S; Wang YL; Knowles DM; Orazi A
Mod Pathol; 2012 Jun; 25(6):815-27. PubMed ID: 22388763
[TBL] [Abstract][Full Text] [Related]
18. Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia.
O'Malley DP; Orazi A; Wang M; Cheng L
Mod Pathol; 2005 Dec; 18(12):1562-8. PubMed ID: 16118625
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia.
O'Malley DP; Orazi A; Dunphy CH; Coleman BR; Marks RA; Wang M; Cheng L
Mod Pathol; 2007 Nov; 20(11):1166-71. PubMed ID: 17704756
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
